Corvus Pharmaceuticals, Inc.
CRVSNasdaqCIK 1626971HealthcareFiscal year ends Dec 31
Reports and events: 201 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-091975 |
| 2026-08-0616:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005317 |
| 2026-07-2216:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-085790 |
| 2026-06-1216:01 ET | 8-K | 5.07 Shareholder vote results | 0001171843-26-004094 |
| 2026-05-1407:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-003397 |
| 2026-05-0716:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057100 |
| 2026-05-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003154 |
| 2026-04-2416:15 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001104659-26-048595 |
| 2026-04-2316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-047735 |
| 2026-03-1308:46 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-027390 |
| 2026-03-1216:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-027047 |
| 2026-03-1216:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001526 |
| 2026-02-0510:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-010750 |
| 2026-01-2720:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000068 |
| 2026-01-2306:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-005968 |
| 2026-01-2016:12 ET | 8-K | 8.01 Other events | 0001104659-26-005035 |
| 2026-01-2007:13 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-004795 |
| 2025-11-0416:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-106259 |
| 2025-11-0416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006973 |
| 2025-10-0216:37 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-096103 |
| 2025-08-0716:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010755 |
| 2025-08-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005180 |
| 2025-06-1316:02 ET | 8-K | 5.07 Shareholder vote results | 0001171843-25-003881 |
| 2025-06-0407:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-003661 |
| 2025-05-1420:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000511 |
| 2025-05-0816:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006966 |
| 2025-05-0816:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-002981 |
| 2025-05-0121:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000444 |
| 2025-04-2516:02 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001558370-25-005552 |
| 2025-04-0916:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-002110 |
| 2025-03-2516:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003621 |
| 2025-03-2516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001689 |
| 2025-01-1307:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000150 |
| 2024-12-1807:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-016343 |
| 2024-11-1216:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015306 |
| 2024-11-1216:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006284 |
| 2024-10-2316:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-24-013518 |
| 2024-08-0616:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011076 |
| 2024-08-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004479 |
| 2024-06-1416:15 ET | 8-K | 5.07 Shareholder vote results | 0001171843-24-003444 |
| 2024-05-0819:55 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000449 |
| 2024-05-0717:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007093 |
| 2024-05-0616:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-131920 |
| 2024-05-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002569 |
| 2024-05-0117:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-127611 |
| 2024-04-2616:05 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001558370-24-005898 |
| 2024-03-1916:02 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-003567 |
| 2024-03-1916:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001454 |
| 2024-01-2317:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-000360 |
| 2023-11-0716:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006818 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.